Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $81,660,525    

Indirect Value

   $12,932,114,466      
Total Shares   142,789,105      
Total Value   $13,013,774,992      


Incyte Corp $32,141,876 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $301,214 Neurogene $16,634 Incyte Corp $32,141,876 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $301,214 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 51 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GHDX Genomic Health Inc Director   –       •       •   2012-02-09 4 B $26.24 $1,473,628 I/I 55,994 7,159,786 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-29 4 B $16.39 $1,481,771 I/I 90,428 3,158,067 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-04 4 B $27.99 $1,488,643 I/I 53,128 229,149 2.25 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2016-01-15 4 B $7.45 $1,491,223 I/I 200,000 12,301,485 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2011-05-27 4 B $27.04 $1,491,922 I/I 55,183 5,729,287 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2011-05-31 4 B $27.46 $1,512,235 I/I 55,039 5,784,326 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2007-11-09 4 B $7.63 $1,517,636 I/I 198,883 4,778,981 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-14 4 B $28.44 $1,586,898 I/I 55,804 7,375,422 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-07 4 B $28.25 $1,597,965 I/I 56,540 230,439 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-06-19 4 S $5.64 $1,609,287 I/I (282,843) 2,274,247 0 -
GHDX Genomic Health Inc Director   –       •       •   2011-02-24 4 B $23.43 $1,700,598 I/I 72,542 5,058,267 2.25 -
INCY Incyte Corp Director   –       •       •   2010-08-09 4 S $14.08 $1,724,784 I/I (122,467) 3,364,533 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-01-31 4 B $57.22 $1,725,084 I/I 30,148 14,364,512 2.25 %
GHDX Genomic Health Inc Director   –       •       •   2011-11-23 4 B $25.71 $1,741,720 I/I 67,427 6,783,952 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-23 4 B $28.12 $1,746,432 I/I 62,098 7,707,045 2.25 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2003-10-06 4 B $10.80 $1,759,320 I/I 162,900 182,834 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-05-22 4 B $5.64 $1,786,493 I/I 316,754 2,803,892 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-25 4 B $16.24 $1,795,466 I/I 110,529 3,067,639 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2011-06-07 4 B $26.14 $1,810,136 I/I 69,198 5,924,995 2.25 -
INCY Incyte Corp Director   –       •       •   2008-07-31 4 B $9.00 $1,814,832 I/I 201,648 3,248,570 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2006-11-15 4 B $5.66 $1,856,016 I/I 328,092 4,080,034 1.5 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2003-10-06 4 B $10.80 $1,858,140 I/I 172,050 195,162 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2008-06-05 4 B $19.50 $1,899,293 I/I 96,863 3,268,072 2.25 -
SGEN Seagen Inc Director   –       •      –    2006-06-09 4 B $4.00 $1,914,744 I/I 478,196 1,145,484 2.1 -
INCY Incyte Corp Director   –       •       •   2011-12-07 4 B $13.21 $1,915,214 I/I 144,903 11,484,023 2.25 -
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51  52   53   54   55   56      
  Page 51 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us